Australia markets close in 5 hours 49 minutes

Thermo Fisher Scientific Inc. (TN8.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
533.90-6.10 (-1.13%)
At close: 07:02PM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 202.60B
Enterprise value 229.06B
Trailing P/E 37.12
Forward P/E 26.81
PEG ratio (5-yr expected) 2.88
Price/sales (ttm)5.27
Price/book (mrq)4.85
Enterprise value/revenue 5.39
Enterprise value/EBITDA 20.19

Trading information

Stock price history

Beta (5Y monthly) 0.80
52-week change 39.09%
S&P500 52-week change 323.57%
52-week high 3557.30
52-week low 3398.00
50-day moving average 3530.81
200-day moving average 3490.22

Share statistics

Avg vol (3-month) 366
Avg vol (10-day) 341
Shares outstanding 5381.71M
Implied shares outstanding 6382.73M
Float 8381.11M
% held by insiders 10.18%
% held by institutions 192.22%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 41.47
Forward annual dividend yield 40.27%
Trailing annual dividend rate 31.44
Trailing annual dividend yield 30.27%
5-year average dividend yield 40.22
Payout ratio 49.24%
Dividend date 3N/A
Ex-dividend date 414 Mar 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 Mar 2024

Profitability

Profit margin 14.20%
Operating margin (ttm)16.68%

Management effectiveness

Return on assets (ttm)4.82%
Return on equity (ttm)13.62%

Income statement

Revenue (ttm)42.49B
Revenue per share (ttm)110.37
Quarterly revenue growth (yoy)-3.40%
Gross profit (ttm)N/A
EBITDA 10.78B
Net income avi to common (ttm)6.03B
Diluted EPS (ttm)14.53
Quarterly earnings growth (yoy)3.00%

Balance sheet

Total cash (mrq)7.25B
Total cash per share (mrq)18.98
Total debt (mrq)35.61B
Total debt/equity (mrq)78.05%
Current ratio (mrq)1.70
Book value per share (mrq)119.12

Cash flow statement

Operating cash flow (ttm)8.93B
Levered free cash flow (ttm)6.08B